Detecting more cases of atrial fibrillation, and at an earlier rate, is key to preventing adverse patient outcomes, said Stephen Voyce, MD, cardiologist and chief of cardiology at Geisinger Community Medical Center for the Geisinger Heart Institute and director of clinical cardiology research.
Detecting more cases of atrial fibrillation, and at an earlier rate, is key to preventing adverse patient outcomes, said Stephen Voyce, MD, cardiologist and chief of cardiology at Geisinger Community Medical Center for the Geisinger Heart Institute and director of clinical cardiology research.
Transcript
How do physicians interpret short-term EKG trace data, and are their approaches efficient in promoting quality care?
Short term data is the 1-time EKG, which is a very short period of time—that may or may not uncover atrial fibrillation if its paroxysmal or intermittent. More recent technologies allow us to monitor patients’ EKG rhythms over a longer period of time. With that, we’re finding more of the atrial fib [fibrillation] that we believe is out there.
How vital are increased preventive measures for atrial fibrillation and what innovations are assisting in accurately detecting patients at risk?
It's really important because the risk with atrial fibrillation is the development of a stroke or heart failure—stroke being the thing that patients maybe fear the most. So, to be able to identify patients with a study like this, so we can target our treatments and strategies–who do we look for? Who do we put these two devices on? Who's best served by that? Then finding those individuals at risk and treating the risk factors–hypertension, obesity, etc, in an effort to try and prevent the atrial fibrillation, as well as, finding it early as possible so the treatments that are effective–anticoagulation to prevent the stroke–can be instituted at an earlier time frame.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More